What's new

Orphan designation: sutimlimab Treatment of autoimmune haemolytic anaemia, 11/02/2025 Positive

Orphan designation: sutimlimab Treatment of autoimmune haemolytic anaemia, 11/02/2025 Positive

Mar 12, 2025 - 17:04
 0
Orphan designation: sutimlimab Treatment of autoimmune haemolytic anaemia, 11/02/2025 Positive
Read More

Tags:

Previous Article

Rivian launches new hands-free driving feature for Gen 2 EVs

Next Article

Orphan designation: Upifitamab rilsodotin Treatment of ovarian cancer, 09/12/202...

Related Posts

Network Portfolio

Network Portfolio

Mar 13, 2025  0

Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials - Scientific guideline

Guideline on quality, non-clinical and clinical require...

Feb 9, 2025  0

Management Board meeting: 13 March 2025, European Medicines Agency, Amsterdam, the Netherlands, 13 March 2025

Management Board meeting: 13 March 2025, European Medic...

Mar 12, 2025  0